GoodCell Adds HSA Bank to its Network, Expanding the Company’s Targeted Reach to HSA & FSA Account Holders
02 nov. 2022 07h30 HE
|
GoodCell
Norwalk, CT, Nov. 02, 2022 (GLOBE NEWSWIRE) -- GoodCell, a life sciences company, added HSA Bank, a division of Webster Bank, N.A., to its growing network comprised of benefits administrators,...
Sema4|GeneDx Commends New Evidence-Based Guidelines from the National Society of Genetic Counselors Recommending Exome Sequencing as a First-Tier Genetic Test for Unexplained Epilepsies
31 oct. 2022 09h00 HE
|
Sema4
STAMFORD, Conn., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, supports the new National Society of Genetic Counselors guidelines recommending exome...
Sema4|GeneDx Announces Results from Phase 1 of SeqFirst Study, Demonstrating Broad Utility of Rapid Whole Genome Sequencing for Critically Ill Newborns
27 oct. 2022 08h00 HE
|
Sema4
-- Abnormal findings reported in 63% of infants in study, change in health management recommended in 88% of cases ---- Sema4|GeneDx contributes to latest data in the SeqFirst study being presented at...
Global Gene Panel Market Size & Share to Surpass $3.09 Bn by 2028| Vantage Market Research
26 oct. 2022 09h02 HE
|
Vantage Market Research
WASHINGTON, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Vantage Market Research analyses that the Gene Panel Market which was USD 2.20 Billion in 2021, would rocket up to USD 3.09 Billion by 2028, and is...
Sema4|GeneDx collaborates on new research demonstrating genome and exome sequencing deliver more diagnostic certainty than multi-gene panels
26 oct. 2022 08h00 HE
|
Sema4
STAMFORD, Conn., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, has collaborated on research debunking a commonly held belief that exome and genome sequencing...
$1.2+ Billion Worldwide Direct-To-Consumer Genetic Testing Industry to 2027 - Rising Public Awareness and Consumer Empowerment Will Support Market Growth
20 oct. 2022 08h08 HE
|
Research and Markets
Dublin, Oct. 20, 2022 (GLOBE NEWSWIRE) -- The "Global Direct-To-Consumer Genetic Testing Market By Test Type, By Technology chips, Targeted Analysis, Whole Genome Sequencing, By Sample, By...
Study Demonstrates the Utility of Exome Sequencing for Diagnosing Autism Spectrum Disorders
13 oct. 2022 08h00 HE
|
Sema4
Research from 19,000 patients with Autism Spectrum Disorders found approximately 90% had prior negative tests, likely contributing to a longer time to diagnosis Data will be presented at the Child...
US Genetic Testing Market Size to Hit USD 10.29 Billion by 2027
07 oct. 2022 07h28 HE
|
Fortune Business Insights
Pune, India, Oct. 07, 2022 (GLOBE NEWSWIRE) -- The US Genetic Testing Market size is expected to achievement momentum by reaching USD 10.29 billion by 2027 while exhibiting an impressive CAGR of...
Global Genetic Testing Market Analysis & Forecasts, 2016-2021 & 2022-2031: Predictive, Carrier, Prenatal and Newborn, Diagnostic, Pharmacogenomic, & Nutrigenomic Testing
06 oct. 2022 06h08 HE
|
Research and Markets
Dublin, Oct. 06, 2022 (GLOBE NEWSWIRE) -- The "Genetic Testing Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global genetic testing market is expected to...
Family Cancer History Still a Mystery to Many Women, Myriad Genetics Survey Finds
28 sept. 2022 09h00 HE
|
Myriad Genetics, Inc.
SALT LAKE CITY, Sept. 28, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced results from a nationwide survey it conducted...